Oncotarget

Vol 10, No 18

March 1, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 18 of Oncotarget features Figure 5, "Simvastatin prolonged survival, inhibited TGF-β signaling and prenylation, and induced apoptosis and autophagy in vivo," by Xiao, et al.

Table of Contents

Editorial

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

https://doi.org/10.18632/oncotarget.26718

Laura Hüser, Peter Altevogt,  and Jochen Utikal
1662-1663
PDF  |  Order a Reprint

A blast from the past: ROS1 on the brain

A blast from the past: ROS1 on the brain

https://doi.org/10.18632/oncotarget.26752

Igor Odintsov, Romel Somwar,  and Monika A. Davare
1664-1666
PDF  |  Order a Reprint

Barriers to pre-treatment genomic characterization of the small renal mass

Barriers to pre-treatment genomic characterization of the small renal mass

https://doi.org/10.18632/oncotarget.26756

Jamil S. Syed, Cedric Lebacle,  and Brian Shuch
1667-1668
PDF  |  Order a Reprint

Research Papers

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

https://doi.org/10.18632/oncotarget.26707

Baptiste Louveau, Julie Delyon, Coralie Reger De Moura, Maxime Battistella, Fanelie Jouenne, Lisa Golmard, Aurelie Sadoux, Marie-Pierre Podgorniak, Ichrak Chami, Oren Marco, Julie Caramel, Stephane Dalle, Jean-Paul Feugeas, Nicolas Dumaz, Celeste Lebbe,  and Samia Mourah
1669-1687
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry

Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry

https://doi.org/10.18632/oncotarget.26706

Keita Tamura, Makoto Horikawa, Shumpei Sato, Hideaki Miyake,  and Mitsutoshi Setou
1688-1703
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

https://doi.org/10.18632/oncotarget.26722

Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon,  and Helmout Modjtahedi
1704-1715
Abstract  |  PDF  |  HTML  |  Order a Reprint

Statins affect human glioblastoma and other cancers through TGF-β inhibition

Statins affect human glioblastoma and other cancers through TGF-β inhibition

https://doi.org/10.18632/oncotarget.26733

Aizhen Xiao, Breanna Brenneman, Desiree Floyd, Laurey Comeau, Kelsey Spurio, Inan Olmez, Jeongwu Lee, Ichiro Nakano, Jakub Godlewski, Agnieszka Bronisz, Noritaka Kagaya, Kazuo Shin-ya,  and Benjamin Purow
1716-1728
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

https://doi.org/10.18632/oncotarget.26739

Till Eichenauer, Mohammad Hussein, Claudia Hube-Magg, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Stefan Steurer, Till S. Clauditz, Andreas M. Luebke, Eike Burandt, Waldemar Wilczak, Andrea Hinsch, David Dum, Burkhard Beyer, Thomas Steuber, Hartwig Huland, Markus Graefen, Ronald Simon, Guido Sauter, Nathaniel Melling, Thorsten Schlomm,  and Sarah Minner
1729-1744
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma

Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma

https://doi.org/10.18632/oncotarget.26741

Susanne Holck, Louise Laurberg Klarskov,  and Lars-Inge Larsson
1745-1755
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC